A Candidate Gene Analysis of Methylphenidate Response in Attention-Deficit/Hyperactivity Disorder

This publication has 50 references indexed in Scilit:

• Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: Association with the dopamine transporter gene (SLC6A3)
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2008
• The Pharmacogenomic Era: Promise for Personalizing Attention Deficit Hyperactivity Disorder Therapy
  Child and Adolescent Psychiatric Clinics of North America, 2008
• No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention‐deficit/hyperactivity disorder
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2006
• Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2006
• Serotonin Transporter Genotype and Acute Subjective Response to Amphetamine
  The American Journal on Addictions, 2006
• Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive-Compulsive Disorder
  American Journal of Human Genetics, 2006
• Dopamine Transporter Genotype and Methylphenidate Dose Response in Children with ADHD
  Neuropsychopharmacology, 2005
• A Genomewide Scan for Attention-Deficit/Hyperactivity Disorder in an Extended Sample: Suggestive Linkage on 17p11
  American Journal of Human Genetics, 2003
• Systematic search for variation in the human norepinephrine transporter gene: Identification of five naturally occurring missense mutations and study of association with major psychiatric disorders
  American Journal of Medical Genetics, 1996
• Dopamine D4 receptor subtypes and response to clozapine
  The Lancet, 1993